Perspectives on 'Communicating evidence about medicines' A report of a one-day workshop held by the Academy of Medical Sciences on 6 June 2016 Disclaimer This report does not represent a formal Academy of Medical Sciences position on how best to communicate evidence about medicines. Rather this document reflects the wide-ranging discussions that took place at the workshop. The report of this meeting will feed into the Academy’s workstream on ‘How can we all best use evidence to judge the potential benefits and harms of medicines?'.1 We hope that this report will also encourage wider discussion about communicating evidence about medicines. We would therefore welcome feedback on the report. For further information, please contact Dr Rachel Brown, Policy Officer at the Academy of Medical Sciences (
[email protected], 020 3141 3223). We are most grateful to Professor Theresa Marteau FMedSci for Chairing this workshop and to Professor Sir David Spiegelhalter OBE FRS for his helpful contributions in the development of this workshop. We are also especially thankful to Dr Paul Robinson, Dr Jacintha Sivarajah, and Dr Catherine Harvey for their contributions to the workshop which were given at short notice, and to all other individuals who contributed to the event. All web references were accessed in June/July 2016. This work is © Academy of Medical Sciences and is licensed under Creative Commons Attribution 4.0 International. 1. Led by Professor Sir John Tooke FMedSci, the workstream also includes workshops on evaluating evidence in health, conflicts of interest, and communicating evidence about medicines in the media.